BIZM Key Stats
|Revenue (Quarterly YoY Growth)||Upgrade|
|EPS Diluted (TTM)||-0.0035|
|EPS Diluted (Quarterly YoY Growth)||Upgrade|
|Net Income (TTM)||-0.4573M|
|Gross Profit Margin (Quarterly)|
|Profit Margin (Quarterly)|
|Dividend Yield (TTM)||0.00%|
|Payout Ratio (TTM)||Upgrade|
Business Wire06/13 05:53
Business Wire06/11 18:45
Business Wire06/11 09:00
Business Wire05/22 19:58
BIZM Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biozoom is down 98.65% over the last year vs S&P 500 Total Return up 16.61%, Abiomed up 2.39%, and Artventive Medical Group up 0.00%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for BIZM
Portfolio Strategies Featuring BIZM
Did Biozoom make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Medical Devices
- Company Website: http://www.biozoom.net
- HQ Country: Germany
- HQ State/Province: N/A
- Incorporation Country: N/A
- Incorporation State/Province: N/A
- Est. Current Fiscal Quarter End: June 30, 2014
- Est. Current Fiscal Year End: March 31, 2015
- Last Fiscal Quarter End: June 30, 2013
- Last Fiscal Year End: March 31, 2013
Biozoom Inc holds certain patents and licenses to technology in the field of devices that use spectroscopics to detect and measure substances within the body or other biological substances.
BIZM Excel Add-In Codes
- Name: =YCI("BIZM","name")
- Description: =YCI("BIZM","description")
- Sector: =YCI("BIZM","sector")
- Industry: =YCI("BIZM","industry")
- Est. Current Fiscal Year End: =YCI("BIZM","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.